By Ari Sass
M.D. Sass, the independent asset management firm founded and led by Martin D. Sass, today announced the launch of its first exchange-traded fund (ETF). M.D. Sass Concentrated Value (Ticker: SASS) will be managed by Ari Sass, President of the firm, and will mirror the Concentrated Value strategy he has managed for institutional clients since 2019. …
By Ari Sass
We are pleased to share that M.D. Sass Concentrated Value has been selected as Gold Status within the Large-Cap Value category for the SMArtX Advisory Solutions Q3 2025 Select List. The SMArtX Select List is the product of a proprietary quantitatively driven screening process designed to identify equity strategies that have the highest probability of …
By Ari Sass
We are excited to announce that M.D. Sass Concentrated Value has surpassed $2 billion in assets under management as the strategy nears its 6.5-year track record. This growth reflects our commitment to continuous improvement, and we remain focused on reinvesting in our business. We look forward to sharing more about several specific growth initiatives as …
By Ari Sass
We pleased to announce the appointment of Shimeng Yu as Senior Equity Analyst, who joined the equity team in early April. In her new role, Shimeng will support the firm’s equity research team as a generalist seeking long-term investment opportunities across sectors. Shimeng brings over a decade of investment experience across prominent hedge funds and …
By Ari Sass
In February, Concentrated Value (“CV”) crossed $1B in AUM, an important milestone that coincides with our five-year track record achieved at the end of 2023. While assets under management has approximately doubled over the past year, we have reinvested a significant amount of the growth back into the business to enhance both our human and …
By Ari Sass
The conclusion of 2023 marked an important milestone for Concentrated Value – the 5th year anniversary of the strategy’s inception. This period has tested our philosophy and process amidst various challenges, including a pandemic, multiple interest rate cycles, inflation, geopolitical tensions, and significant market volatility. We are proud of the results we have achieved despite …
The inclusion of links from this site does not imply endorsement by M.D. Sass. M.D. Sass makes no endorsement, express or implied, of any links to or from its site, nor is it responsible for the content or activities of any linked sites. Contact the external site for answers to questions regarding its content.